• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Strategy for overcoming drug resistance of leukemic stem cells by using micro-RNA targeted for telomerase

Research Project

Project/Area Number 22501053
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Clinical oncology
Research InstitutionTokyo Women's Medical University

Principal Investigator

YAMADA Osamu  東京女子医科大学, 医学部, 准教授 (30167712)

Project Period (FY) 2010 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywordsテロメレース / マイクロ RNA / 薬剤耐性 / 白血病幹細胞 / MDR1 / メチレーション / STAT5 / 分子標的治療 / マイクロRNA
Research Abstract

The object of our experiment is to know microRNA regulating telomerase expression. Together with the results of methylation analysis of drug resistant cells, we tried to develop therapeutic strategies for overcoming drug resistance of cancer stem cells. As a result, methylation level of both telomerase and MDR1 promoter lesion was stable during acquisition of drug resistance. Instead, increased expression of telomerase and MDR1 protein which was caused through the activation of transcription factor STAT5, was observed.

Report

(4 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Annual Research Report
  • 2010 Annual Research Report
  • Research Products

    (39 results)

All 2013 2012 2011 2010 Other

All Journal Article (23 results) (of which Peer Reviewed: 11 results) Presentation (11 results) Book (1 results) Patent(Industrial Property Rights) (4 results) (of which Overseas: 1 results)

  • [Journal Article] Emergence of a Variant BCR-ABL Translocation, t(9;22;21), in a Patient with the JAK2V617F Mutation: Evidence for Secondary Acquisition of BCR-ABL in the JAK2V617F Clone2013

    • Author(s)
      Yamada O, Mahfoudhi E, Plo I, Ozaki, K, Nakatake M, Akiyama M, Yamada H, Kawauchi K and Vainchenker W
    • Journal Title

      Journal of Clinical Oncology

      Volume: (in press)

    • Related Report
      2012 Final Research Report
  • [Journal Article] 急性骨髄性白血病の分子病態の解析2013

    • Author(s)
      勝見重昭、川内喜代隆、尾崎幸次、清水 悟、木村 利美、泉二登志子、山田 修
    • Journal Title

      癌と化学療法

      Volume: (印刷中)

    • Related Report
      2012 Final Research Report
  • [Journal Article] Telomeres and telomerase in hematology (Review)2013

    • Author(s)
      Yamada O
    • Journal Title

      The Journal of Tokyo Women's Medical University

      Volume: 83 Pages: 88-106

    • Related Report
      2012 Final Research Report
  • [Journal Article] Amplification of the human epidermal growth factor receptor 2 gene in differentiated thyroid cancer correlates with telomere shortening2013

    • Author(s)
      Sugishita Y. Yamada O et al
    • Journal Title

      International Journal of Oncology

      Volume: 42 Pages: 1589-1596

    • Related Report
      2012 Annual Research Report 2012 Final Research Report
  • [Journal Article] Emergence of a BCR-ABL Translocation in a Patient with the JAK2V617F Mutation:2013

    • Author(s)
      Yamada O. et al.
    • Journal Title

      Journal of Clinical Oncology

      Volume: in press

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Telomeres and telomerase in hematology2013

    • Author(s)
      Yamada O.
    • Journal Title

      The Journal of Tokyo Women’s Medical University

      Volume: 83

    • NAID

      110009575062

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 急性骨髄性白血病の分子病態の解析2013

    • Author(s)
      勝見重昭
    • Journal Title

      癌と化学療法

      Volume: 40 Pages: 471-477

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] JAK-STAT and JAK-PI3K-mTORC1 pathways regulate telomerase transcriptionally and post-translationally in ATL cells2012

    • Author(s)
      Yamada O, Ozaki K, Akiyama M and Kawauchi K
    • Journal Title

      Molecular Cancer Therapeutics

      Volume: 11 Pages: 1112-21

    • NAID

      120005262992

    • Related Report
      2012 Final Research Report
  • [Journal Article] JAK-STAT and JAK-PI3K-mTORC1 pathways regulate telomerase transcriptionally and post-translationally in ATL cells.2012

    • Author(s)
      Yamada O. et al.
    • Journal Title

      Molecular Cancer Therapeutics

      Volume: 11 Issue: 5 Pages: 1112-1121

    • DOI

      10.1158/1535-7163.mct-11-0850

    • NAID

      120005262992

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] JAK-STAT and JAK-PI3K-mTORC1 pathways regulate telomerase transcriptionally and post-translationally in ATL cells2012

    • Author(s)
      Yamada Osamu, et al
    • Journal Title

      Molecular Cancer Therapeutics

      Volume: (in press)

    • NAID

      120005262992

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Activation of STAT5 confers imatinib resistance on leukemic cells through the transcription of TERT and MDR12011

    • Author(s)
      Yamada O, Ozaki K, Furukawa T, Machida M, Wang YH, Motoji T, et al
    • Journal Title

      Cellular Signalling

      Volume: 23 Pages: 1119-27

    • NAID

      120003145454

    • Related Report
      2012 Final Research Report
  • [Journal Article] Erythropoietin activates telomerase through transcriptional and posttranscriptional regulation in human erythroleukemic JAS-REN-A cells2011

    • Author(s)
      Akiyama M, Kawano T, Mikami-Terao Y, Agawa-Ohta M, Yamada O, Ida H, Yamada H
    • Journal Title

      Leukemia Research

      Volume: 35 Pages: 416-418

    • Related Report
      2012 Final Research Report 2011 Annual Research Report
  • [Journal Article] Telomere 長解析と、Telomerase, HER2/neu の発現による甲状腺 癌 の 補 助 診 断2011

    • Author(s)
      杉下佳之、神森眞、山田 修、鈴木茂一、山崎和子、福森龍也 ほか
    • Journal Title

      内分泌外科

      Volume: 28 Pages: 226-31

    • NAID

      10030391879

    • Related Report
      2012 Final Research Report
  • [Journal Article] Activation of STAT5 confers imatinib resistance on leukemic cells through the transcription of TERT and MDR12011

    • Author(s)
      Yamada Osamu, et.al.
    • Journal Title

      Cellular Signalling

      Volume: 23 Pages: 1119-1127

    • NAID

      120003145454

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Telomere長解析と、Telomerase, HER2/neuの発現による甲状腺癌の補助診断2011

    • Author(s)
      杉下佳之, ら
    • Journal Title

      内分泌外科

      Volume: 28 Pages: 226-231

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 後天性血友病A2011

    • Author(s)
      近藤年昭, ら
    • Journal Title

      東京女子医科大学雑誌

      Volume: 81 Pages: 221-222

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Akt and PKC are involved not only in upregulation of telomerase activity but also in cell differentiation-related function via mTORC2 in leukemia cells2010

    • Author(s)
      Yamada O, Ozaki K, Nakatake N, Kakiuchi Y, Akiyama M, Mitsuishi T, et al
    • Journal Title

      Histochem Cell Biol

      Volume: 134 Pages: 555-63

    • NAID

      120003558167

    • Related Report
      2012 Final Research Report
  • [Journal Article] Combined analysis of cell growth and apoptosis-regulating proteins in HPVs associated anogenital tumors2010

    • Author(s)
      Mitsuishi T, Tokunaga K, Iwabu Y, Sata T, Kaneko T, Ohara K,Yamada O.et al
    • Journal Title

      BMC Cancer

      Volume: 10 Pages: 118-28

    • Related Report
      2012 Final Research Report
  • [Journal Article] 多発性骨髄腫に対する thalidomide 療法の効果に関与する因子と効果判定時期2010

    • Author(s)
      縣宗彦, 鮫島勇一,小田哲朗,近藤年昭,石山みどり,安並毅、山田 修 ほか
    • Journal Title

      臨床血液

      Volume: 51 Pages: 189-95

    • NAID

      10026332405

    • Related Report
      2012 Final Research Report
  • [Journal Article] Akt and PKC are involved not only in upregulation of telomerase activity but also in cell differentiation-related function via mTORC2 inleukemia cells2010

    • Author(s)
      Yamada Osamu, et.al
    • Journal Title

      Histochem.Cell.Biol.

      Volume: 134 Pages: 555-563

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Combined analysis of cell growth and apoptosis-regulating proteins in HPVs associated anogenital tumors2010

    • Author(s)
      Mitsuishi Tsuyoshi, et al.
    • Journal Title

      BMC Cancer.

      Volume: 10 Pages: 118-128

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The role of JAK-STAT and related signals for telomerase activation in hematologic malignancies

    • Author(s)
      Yamada O. and Kawauchi K
    • Journal Title

      JAK-STAT journal

      Volume: (in press)

    • Related Report
      2012 Final Research Report
  • [Journal Article] Activation of STAT5 confers imatinib resistance on leukemic cells through the transcription of TERT and MDR1

    • Author(s)
      Yamada Osamu, et.al
    • Journal Title

      Cellular Signalling

      Volume: (in press)

    • NAID

      120003145454

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Presentation] 耳介鍼刺激の摂食関連サイトカインと体重への影響2013

    • Author(s)
      伊藤久敬、 山田 修、吉良有二、田中建志
    • Organizer
      第64回日本東洋医学会学術総会
    • Place of Presentation
      鹿児島
    • Year and Date
      2013-05-31
    • Related Report
      2012 Final Research Report
  • [Presentation] Emergence of a BCR-ABL Translocation in a Patient with the JAK2V617F Mutation: Evidence for Secondary Acquisition of BCR-ABL in the JAK2V617F Clone2012

    • Author(s)
      Yamada Osamu, Ozaki Kohji, Nakatake Mayuka et al
    • Organizer
      第74回日本血液学会総会
    • Place of Presentation
      京都
    • Year and Date
      2012-10-19
    • Related Report
      2012 Final Research Report
  • [Presentation] Emergence of CML in a PMF patient with JAK2V617F mutation before therapeutic manipulation.2012

    • Author(s)
      Yamada O. et al.
    • Organizer
      第74回日本血液学会学術集会
    • Place of Presentation
      京都
    • Related Report
      2012 Annual Research Report
  • [Presentation] MLL is a novel target of anti-myeloma therapy and it is degraded by inhibitors of histone deacetylase (HDAC) and HSP90.2011

    • Author(s)
      Imai1 Y, Ohta Eri, Wang Y, Ding Y, YamadaO et al
    • Organizer
      第73回日本血液学会総会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-15
    • Related Report
      2012 Final Research Report
  • [Presentation] Measurement of telomere length using quantitative PCR in hematologiccells.2011

    • Author(s)
      Yamada Osamu, Ozaki Kohji, Kawauchi Kiyotaka et al.
    • Organizer
      第73回日本血液学会総会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-15
    • Related Report
      2012 Final Research Report
  • [Presentation] JAK-STAT and JAK-PI3K-mTORC1 pathways regulate telomerase transcriptionally and post-translationally in ATL cells2011

    • Author(s)
      Kawauchi Kiyotaka and Yamada Osamu
    • Organizer
      第73回日本血液学会総会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-15
    • Related Report
      2012 Final Research Report
  • [Presentation] Measurement of telomere length using quantitative PCR in hematologic cells2011

    • Author(s)
      Yamada Osamu, et al
    • Organizer
      日本血液学会総会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-15
    • Related Report
      2011 Annual Research Report
  • [Presentation] JAK-STAT and JAK-PI3K-mTORC1 pathways regulate telomerase transcriptionally and post-translationally in ATL cells2011

    • Author(s)
      Kawauchi Kiyotaka, et al
    • Organizer
      日本血液学会総会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-14
    • Related Report
      2011 Annual Research Report
  • [Presentation] テロメア長解析と、テロメレース、HER2/neuの発現による甲状腺癌の補助診断2011

    • Author(s)
      杉下 佳之, 神森 眞, 山田 修
    • Organizer
      第23回日本内分泌外科学会総会
    • Place of Presentation
      東京
    • Year and Date
      2011-07-07
    • Related Report
      2012 Final Research Report
  • [Presentation] 急性骨髄性白血病細胞の薬剤感受性とテロメレース2010

    • Author(s)
      勝見重昭, ら
    • Organizer
      第72日本血液学会学術集会
    • Place of Presentation
      横浜
    • Year and Date
      2010-09-24
    • Related Report
      2010 Annual Research Report
  • [Presentation] 急性骨髄性白血病細胞の薬剤感受性とテロメレース.2010

    • Author(s)
      勝見重昭、尾崎幸次、秋山政晴、川内喜代隆、泉二登志子、山田修
    • Organizer
      第72 日本血液学会学術集会
    • Place of Presentation
      横浜
    • Year and Date
      2010-09-14
    • Related Report
      2012 Final Research Report
  • [Book] 私、医者に行ったほうがいいですか-身体の変調に気づいたら読む本-2010

    • Author(s)
      山田修、吉良有二
    • Total Pages
      327
    • Publisher
      日本経済新聞出版社
    • Related Report
      2010 Annual Research Report
  • [Patent(Industrial Property Rights)] テロメア配列増幅用プライマー2013

    • Inventor(s)
      山田 修
    • Industrial Property Rights Holder
      東京女子医科大学
    • Filing Date
      2013-05-09
    • Related Report
      2012 Final Research Report
    • Overseas
  • [Patent(Industrial Property Rights)] テロメア配列増幅用プライマー2013

    • Inventor(s)
      山田 修
    • Industrial Property Rights Holder
      東京女子医科大学
    • Industrial Property Rights Type
      特許
    • Filing Date
      2013-03-26
    • Related Report
      2012 Annual Research Report
  • [Patent(Industrial Property Rights)] テロメア配列増幅用プライマー2011

    • Inventor(s)
      山田 修
    • Industrial Property Rights Holder
      東京女子医科大学
    • Filing Date
      2011-10-13
    • Related Report
      2012 Final Research Report
  • [Patent(Industrial Property Rights)] テロメア配列増幅用プライマー2011

    • Inventor(s)
      山田修
    • Industrial Property Rights Holder
      東京女子医科大学
    • Filing Date
      2011-10-13
    • Related Report
      2011 Annual Research Report

URL: 

Published: 2010-08-23   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi